Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Genes (Basel) ; 12(7)2021 06 30.
Article in English | MEDLINE | ID: mdl-34208970

ABSTRACT

Cadmium (Cd) is one of the most toxic pollutants for health due to its accumulation in several tissues, including testis. This report confirms that Cd increased oxidative stress and apoptosis of germ and somatic cells and provoked testicular injury, as documented by biomolecular and histological alterations, i.e., CAT and SOD activity, the protein level of steroidogenic enzymes (StAR and 3ß-HSD), and morphometric parameters. Additionally, it further documents the melatonin (MLT) coadministration produces affects in mitigating Cd-induced toxicity on adult rat testis, as demonstrated by the reduction of oxidative stress and apoptosis, with reversal of the observed histological changes; moreover, a role of MLT in partially restoring steroidogenic enzymes expression was evidenced. Importantly, the cytoarchitecture of testicular cells was perturbed by Cd exposure, as highlighted by impairment of the expression and localization of two cytoskeleton-associated proteins DAAM1 and PREP, which are involved in the germ cells' differentiation into spermatozoa, altering the normal spermatogenesis. Here, for the first time, we found that the co-treatment with MLT attenuated the Cd-induced toxicity on the testicular DAAM1 and PREP expression. The combined findings provide additional clues about a protective effect of MLT against Cd-induced testicular toxicity by acting on DAAM1 and PREP expression, encouraging further studies to prove its effectiveness in human health.


Subject(s)
Cadmium/toxicity , Cytoskeletal Proteins/metabolism , Gene Expression Regulation/drug effects , Melatonin/pharmacology , Oxidative Stress/drug effects , Prolyl Oligopeptidases/metabolism , Testis/drug effects , Animals , Antioxidants/pharmacology , Apoptosis , Cytoskeletal Proteins/genetics , Male , Prolyl Oligopeptidases/genetics , Rats , Rats, Wistar , Spermatogenesis , Testis/metabolism , Testis/pathology
2.
Biochemistry (Mosc) ; 86(6): 704-715, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34225593

ABSTRACT

Early-life stress is a risk factor for the development of behavioral and cognitive disorders in humans and animals. Such stressful situations include social isolation in early postnatal ontogenesis. Behavioral and cognitive impairments associated with neuroplastic changes in brain structures. We have found that after ten weeks of social isolation, male Wistar rats show behavioral abnormalities and cognitive deficit, accompanied by an increase in the relative expression of gene encoding serine protease prolyl endopeptidase (PREP, EC 3.4.21.26) in the brain frontal cortex. The present study aimed to assess synaptophysin (SYP), brain-derived neurotrophic factor precursor (proBDNF), and PREP expression using Western blot in the brain structures - the hippocampus, frontal cortex, and striatum of the rats subjected to prolonged social isolation compared with group-housed animals. Twenty Wistar rats were used for this study (10 males and 10 females). Experimental animals (5 males and 5 females) were kept one per cage for nine months, starting from the age of one month. Ten-month-old socially isolated rats showed memory deficit in passive avoidance paradigm and Morris Water Maze and reactivity to novelty reduction. We used monoclonal antibodies for the Western blot analysis of the expression of SYP, proBDNF, and PREP in the rat brain structures. Social isolation caused a proBDNF expression reduction in the frontal cortex in females and a reduction in PREP expression in the striatum in males. These data suppose that neurotrophic factors and PREP are involved in the mechanisms of behavioral and cognitive impairments observed in the rats subjected to prolonged social isolation with an early life onset.


Subject(s)
Brain-Derived Neurotrophic Factor/genetics , Brain/metabolism , Prolyl Oligopeptidases/genetics , Social Isolation , Stress, Psychological/metabolism , Animals , Female , Frontal Lobe/metabolism , Gene Expression Regulation , Hippocampus/metabolism , Male , Neuronal Plasticity , Rats , Rats, Wistar , Stress, Psychological/enzymology , Stress, Psychological/genetics , Synaptophysin/genetics
3.
Proteins ; 89(6): 614-622, 2021 06.
Article in English | MEDLINE | ID: mdl-33426726

ABSTRACT

Puromycin-hydrolizing peptidases have been described as members of the prolyl oligopeptidase peptidase family. These enzymes are present across all domains of life but still little is known of the homologs found in the pathogenic bacterium Mycobacterium tuberculosis. The crystal structure of a M. tuberculosis puromycin hydrolase peptidase has been determined at 3 Angstrom resolution, revealing a conserved prolyl oligopeptidase fold, defined by α/ß-hydrolase and ß-propeller domains with two distinctive loops that occlude access of large substrates to the active site. The enzyme displayed amino peptidase activity with a substrate specificity preference for hydrophobic residues in the decreasing order of phenylalanine, leucine, alanine and proline. The enzyme's active site is lined by residues Glu564 for the coordination of the substrates amino terminal moiety and His561, Val608, Tyr78, Trp306, Phe563 and Ty567 for the accommodation of hydrophobic substrates. The availability of a crystal structure for puromycin hydrolase of M. tuberculosis shall facilitate the development of inhibitors with therapeutic applications.


Subject(s)
Aminopeptidases/chemistry , Bacterial Proteins/chemistry , Hydrolases/chemistry , Mycobacterium tuberculosis/enzymology , Prolyl Oligopeptidases/chemistry , Puromycin/chemistry , Alanine/chemistry , Alanine/metabolism , Aminopeptidases/genetics , Aminopeptidases/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Catalytic Domain , Cloning, Molecular , Crystallography, X-Ray , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Genetic Vectors/chemistry , Genetic Vectors/metabolism , Hydrolases/genetics , Hydrolases/metabolism , Hydrophobic and Hydrophilic Interactions , Kinetics , Leucine/chemistry , Leucine/metabolism , Models, Molecular , Mycobacterium tuberculosis/chemistry , Phenylalanine/chemistry , Phenylalanine/metabolism , Proline/chemistry , Proline/metabolism , Prolyl Oligopeptidases/genetics , Prolyl Oligopeptidases/metabolism , Protein Binding , Protein Conformation, alpha-Helical , Protein Conformation, beta-Strand , Protein Interaction Domains and Motifs , Puromycin/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Substrate Specificity
4.
Life Sci ; 270: 119131, 2021 Apr 01.
Article in English | MEDLINE | ID: mdl-33516698

ABSTRACT

AIMS: Prolyl endopeptidase (PREP) is a serine endopeptidase widely distributed in the body, and accumulated evidence suggests that PREP participates in inflammation and oxidative stress. Here, we explored the effect of PREP gene disruption on hepatic inflammation and oxidative stress status in a methionine-choline-deficient (MCD)-induced nonalcoholic steatohepatitis (NASH) model. MAIN METHODS: PREP gene disruption (PREPgt) mice and wild-type (WT) littermates were placed on a control or an MCD diet for 4 weeks, respectively. The liver histopathological analysis and the number of inflammatory cells were determined by hematoxylin-eosin (HE) and immunohistochemical staining. Inflammation-associated genes and cytokine levels in liver tissue were evaluated by quantitative PCR and ELISA. The levels of P53, Sesn2, Nrf2, HO-1, and oxidative stress indicators in mice and the palmitic acid (PA)-treated human hepatocellular carcinoma cells (HepG2) were examined by immunoblotting and commercially available kits, respectively. KEY FINDINGS: We found that PREP expression was upregulated in the MCD-induced NASH model. In addition, PREP disruption alleviated MCD-induced hepatic inflammation accompanied by diminished infiltration of inflammatory cells and secretion of inflammatory mediators. More importantly, the results of this study indicate that targeting PREP can improve oxidative stress status in the liver of MCD-diet mice and PA-exposed HepG2 cells. The effect is most likely mediated by the activation of P53 and its downstream signaling pathways (Sesn2/Nrf2/HO-1). SIGNIFICANCE: Our results showed that PREP disruption (or inhibition) could decrease oxidative stress and inflammation and improve liver function, indicating that targeting PREP might be a new potential therapeutic option for NAFLD/NASH.


Subject(s)
Fatty Liver/metabolism , Prolyl Oligopeptidases/metabolism , Prolyl Oligopeptidases/physiology , Animals , Choline/metabolism , Choline Deficiency/complications , Cytokines/metabolism , Diet , Fatty Liver/drug therapy , Hep G2 Cells , Humans , Inflammation/metabolism , Liver/metabolism , Male , Methionine/deficiency , Methionine/metabolism , Mice , Mice, Inbred C57BL , NF-kappa B/metabolism , Oxidative Stress/drug effects , Prolyl Oligopeptidases/genetics , Signal Transduction
5.
Genes (Basel) ; 11(7)2020 07 19.
Article in English | MEDLINE | ID: mdl-32707643

ABSTRACT

Congenital myasthenic syndrome-22 (CMS22, OMIM 616224) is a very rare recessive hereditary disorder. At the moment, ten CMS22 patients are described, with the disorder caused by nine different Loss-of-Function mutations and 14 gross deletions in the PREPL gene. The materials for our study were DNA samples of five family members: two patients with myasthenia, their healthy sibling and parents. Clinical exome analysis was carried out for one patient, then the whole family was checked for target variants with Sanger sequencing, quantitative multiplex ligation-dependent probe amplification, and chromosome 2 microsatellite markers study. To determine the functional significance of the splicing variant, we applied the minigene assay. The cause of the proband's disorder is a compound heterozygous state of two previously non-described pathogenic PREPL variants: a c.1528C>T (p.(Arg510Ter)) nonsense mutation and a c.2094G>T pseudo-missense variant, which, simultaneously with a p.(Lys698Asn) amino acid substitution, affects splicing, leading to exon 14 skipping in mRNA. The second patient's disorder was caused by a homozygous nonsense c.1528C>T (p.(Arg510Ter)) mutation due to maternal uniparental disomy (UPD) of chromosome 2. In this study, we describe a unique case, in which two siblings with a rare disorder have different pathologic genotypes.


Subject(s)
Genotype , Myasthenic Syndromes, Congenital/genetics , Prolyl Oligopeptidases/genetics , Child , Codon, Nonsense , Humans , Male , Myasthenic Syndromes, Congenital/pathology , Pedigree , RNA Splicing , Siblings , Uniparental Disomy
6.
Enzyme Microb Technol ; 138: 109548, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32527522

ABSTRACT

A novel prolyl endopeptidase from Stenotrophomonas maltophilia, SmPEP, was discovered and characterized. The specific activity of the recombinant SmPEP expressed by Escherichia coli BL21 (DE3), was 68.3 U/mg at pH 8.0 and 37 °C. In order to improve the substrate specificity for long-chain peptide, rational design was applied based on the structure constructed by homology modeling. Inter-domain sites within the ß-propeller domain were chosen for the mutation to weaken the inter-domain interaction and form an open conformation for long-chain substrate entering into the active site. The substrate specificity on a designed long-chain substrate, PQPQLPYPQPQLP, of the mutants F263A and E184 G increased 8.77 and 5.75 times respectively versus wild-type. After the saturated mutation of the both sites, the reactive rate of mutant F263 V on 13-mer peptide was 10.2 times higher than that of the wild-type. Then the mutant F263 V was used in the hydrolysis of casein, and the ACE inhibitory activity of the hydrolysate was significantly improved compared with wild type enzyme, which verified the efficiency of the design strategy.


Subject(s)
Prolyl Oligopeptidases/chemistry , Prolyl Oligopeptidases/metabolism , Stenotrophomonas maltophilia/enzymology , Amino Acid Sequence , Angiotensin-Converting Enzyme Inhibitors/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Caseins/metabolism , Catalytic Domain , Escherichia coli/genetics , Escherichia coli/metabolism , Hydrolysis , Models, Molecular , Mutation , Peptides/chemistry , Peptides/metabolism , Prolyl Oligopeptidases/genetics , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Stenotrophomonas maltophilia/genetics , Structure-Activity Relationship , Substrate Specificity
7.
J Biochem ; 168(5): 499-508, 2020 Nov 01.
Article in English | MEDLINE | ID: mdl-32597969

ABSTRACT

Prolyl endopeptidase from an aerobic and Gram-negative thermophile Meiothermus ruber H328 (MrPEP) was purified in native and recombinant forms, but both preparations had comparable characteristics. Production of the native MrPEP was increased 10-fold by adding intact chicken feathers. The gene for MrPEP (mrH_2860) was cloned from the genome of strain H328 and found to have no signal sequence at the N-terminus. MrPEP is composed of two major domains: the ß-propeller domain and the peptidase domain with a typical active site motif and catalytic triad. Based on extensive investigations with different types of peptide substrates and FRETS-25Xaa libraries, MrPEP showed strict preferences for Pro residue at the P1 position but broader preferences at the P2 and P3 positions in substrate specificity with stronger affinity for residues at the P3 position of substrate peptides that are longer than four residues in length. In conclusion, the molecular characterization of MrPEP resembles its animal counterparts more closely than bacterial counterparts in function and structure.


Subject(s)
Bacteria/enzymology , Bacterial Proteins/metabolism , Feathers/microbiology , Prolyl Oligopeptidases/metabolism , Amino Acid Sequence , Animals , Bacterial Proteins/genetics , Catalysis , Chickens , Feathers/metabolism , Prolyl Oligopeptidases/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Homology , Substrate Specificity
8.
BMC Genomics ; 21(1): 440, 2020 Jun 26.
Article in English | MEDLINE | ID: mdl-32590929

ABSTRACT

BACKGROUND: Amanitin-producing mushrooms, mainly distributed in the genera Amanita, Galerina and Lepiota, possess MSDIN gene family for the biosynthesis of many cyclopeptides catalysed by prolyl oligopeptidase (POP). Recently, transcriptome sequencing has proven to be an efficient way to mine MSDIN and POP genes in these lethal mushrooms. Thus far, only A. palloides and A. bisporigera from North America and A. exitialis and A. rimosa from Asia have been studied based on transcriptome analysis. However, the MSDIN and POP genes of many amanitin-producing mushrooms in China remain unstudied; hence, the transcriptomes of these speices deserve to be analysed. RESULTS: In this study, the MSDIN and POP genes from ten Amanita species, two Galerina species and Lepiota venenata were studied and the phylogenetic relationships of their MSDIN and POP genes were analysed. Through transcriptome sequencing and PCR cloning, 19 POP genes and 151 MSDIN genes predicted to encode 98 non-duplicated cyclopeptides, including α-amanitin, ß-amanitin, phallacidin, phalloidin and 94 unknown peptides, were found in these species. Phylogenetic analysis showed that (1) MSDIN genes generally clustered depending on the taxonomy of the genus, while Amanita MSDIN genes clustered depending on the chemical substance; and (2) the POPA genes of Amanita, Galerina and Lepiota clustered and were separated into three different groups, but the POPB genes of the three distinct genera were clustered in a highly supported monophyletic group. CONCLUSIONS: These results indicate that lethal Amanita species have the genetic capacity to produce numerous cyclopeptides, most of which are unknown, while lethal Galerina and Lepiota species seem to only have the genetic capacity to produce α-amanitin. Additionally, the POPB phylogeny of Amanita, Galerina and Lepiota conflicts with the taxonomic status of the three genera, suggesting that underlying horizontal gene transfer has occurred among these three genera.


Subject(s)
Agaricales/classification , Fungal Proteins/genetics , Gene Expression Profiling/methods , Peptides, Cyclic/biosynthesis , Agaricales/genetics , Agaricales/metabolism , Amanitins/biosynthesis , Asia , Evolution, Molecular , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , Gene Transfer, Horizontal , Multigene Family , North America , Phylogeny , Prolyl Oligopeptidases/genetics , Prolyl Oligopeptidases/metabolism , Species Specificity
9.
Biomed Pharmacother ; 128: 110253, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32447211

ABSTRACT

Previous studies have shown that prolyl oligopeptidase (PREP) negatively regulates autophagy and increases the aggregation of alpha-synuclein (αSyn), linking it to the pathophysiology of Parkinson's disease. Our earlier results have revealed that the potent small molecular PREP inhibitor KYP-2047 is able to increase autophagy and decrease dimerization of αSyn but other PREP inhibitors have not been systematically studied for these two protein-protein interaction mediated biological functions of PREP. In this study, we characterized these effects for 12 known PREP inhibitors with IC50-values ranging from 0.2 nM to 1010 nM. We used protein-fragment complementation assay (PCA) to assess αSyn dimerization and Western Blot of microtubule-associated protein light chain 3B II (LC3B-II) and a GFP-LC3-RFP expressing cell line to study autophagy. In addition, we tested selected compounds in a cell-free αSyn aggregation assay, native gel electrophoresis, and determined the compound concentration inside the cell by LC-MS. We found that inhibition of the proteolytic activity of PREP did not predict decreased αSyn dimerization or increased autophagy, and we also confirmed that this result did not simply reflect concentration differences of the compounds inside the cell. Thus, PREP ligands regulate the effect of PREP on autophagy and αSyn aggregation through a conformational stabilization of the enzyme that is not equivalent to inhibiting its proteolytic activity.


Subject(s)
Antiparkinson Agents/pharmacology , Autophagy/drug effects , Proline/analogs & derivatives , Prolyl Oligopeptidases/antagonists & inhibitors , Serine Proteinase Inhibitors/pharmacology , alpha-Synuclein/metabolism , Dose-Response Relationship, Drug , HEK293 Cells , Humans , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Proline/pharmacology , Prolyl Oligopeptidases/genetics , Prolyl Oligopeptidases/metabolism , Protein Aggregates , Protein Multimerization
10.
Mol Reprod Dev ; 87(5): 565-573, 2020 05.
Article in English | MEDLINE | ID: mdl-32329151

ABSTRACT

During the differentiation of the male gamete, there is a massive remodeling in the shape and architecture of all the cells of the seminiferous epithelium. The cytoskeleton, as well as many associated proteins with it, plays a pivotal role in this process. The testis is particularly susceptible to environmental pollutant, which can lead to injury and impairment of normal spermatozoa production. Cadmium (Cd) is one of the major chemical environmental toxicants in economically developed countries. Food and cigarettes are the main sources of exposure to this element. Here, the protective role of zinc (Zn) to prevent the testicular toxicity in male adult rats after prenatal and during lactation exposure to Cd has been assessed. Altered testicular histology at the interstitial and germinal levels was found, whereas Zn supply completely corrected Cd toxicity. Moreover, the effects of these metals on the testicular expression and localization of the protease prolyl endopeptidase (PREP) were evaluated. Interestingly, the results showed an increase of PREP messenger RNA and protein. Data were corroborated by immunofluorescence. This study raises the possibility of using PREP as a new fertility marker.


Subject(s)
Cadmium/toxicity , Prolyl Oligopeptidases/genetics , Testis/drug effects , Animals , Animals, Newborn , Animals, Suckling , Cytoprotection/drug effects , Endocrine Disruptors/toxicity , Environmental Pollutants/toxicity , Female , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Lactation/drug effects , Lactation/genetics , Lactation/metabolism , Male , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/genetics , Prenatal Exposure Delayed Effects/metabolism , Prolyl Oligopeptidases/metabolism , Rats , Spermatogenesis/drug effects , Spermatogenesis/genetics , Testis/embryology , Testis/growth & development , Testis/metabolism , Zinc/pharmacology
11.
J Agric Food Chem ; 68(18): 5129-5137, 2020 May 06.
Article in English | MEDLINE | ID: mdl-32297517

ABSTRACT

Prolyl endopeptidases (PEPs) hydrolyze proteins to yield bioactive peptides and are effective in the treatment of celiac disease. However, the catalytic efficiency of PEPs still has the potential to be improved, which could further strengthen their industrial and therapeutic applications. Herein, a novel rational design strategy based on a "near-attack conformation" of the catalytic state of PEP was adopted. Constrained dynamic simulations were applied, followed by the virtual screening of potentially favorable mutants according to their binding free energy. We redesigned Sphaerobacter thermophiles PEP with high-temperature activity/stability, a wide range of pH stabilities, and high proline specificity. As a result, the kcat value of two PEP mutants (I462W and Q560Y) increased by 208.2 and 150.1%, respectively, and the kcat/KM increased by 32.7 and 6.3%, respectively. These data revealed that the PEP mutants had improved catalytic efficiency and that our strategy can be applied for enzyme engineering.


Subject(s)
Bacterial Proteins/chemistry , Chloroflexi/enzymology , Prolyl Oligopeptidases/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biocatalysis , Chloroflexi/chemistry , Chloroflexi/genetics , Enzyme Stability , Hydrogen-Ion Concentration , Kinetics , Prolyl Oligopeptidases/genetics , Prolyl Oligopeptidases/metabolism , Protein Conformation , Substrate Specificity
12.
Mol Genet Genomic Med ; 8(3): e1144, 2020 03.
Article in English | MEDLINE | ID: mdl-31985178

ABSTRACT

BACKGROUND: Congenital myasthenic syndrome 22 (CMS22) is a rare autosomal recessive disorder due to isolated PREPL deficiency and characterized by neonatal hypotonia, muscular weakness, and feeding difficulties. Eight such cases have already been reported, while maternal uniparental disomy with a PREPL pathogenic mutation has never been involved. METHODS: Trio whole-exome sequencing (WES), comparative genomic hybridization microarray (arry-CGH), and Sanger sequencing were performed on a 6-month-old girl with severe neonatal hypotonia and feeding difficulties. Also, the phenotype and genotype of reported CMS22 patients were reviewed. RESULTS: In this female infant, we identified a novel homozygous frameshift mutation in PREPL (c.1282_1285delTTTG, p.Phe428Argfs*18) by trio-WES. Sanger sequencing confirmed that her mother was heterozygous and her father was normal. Trio-WES data showed that 96.70% (1668/1725) variants on chromosome 2 were homozygous and maternally inherited, suggesting maternal uniparental disomy of chromosome 2 [UPD(2)mat]. Array-CGH did not show copy number variants (CNVs) but revealed complete UPD(2). CONCLUSION: To date, nine patients with CMS22 have been reported including our patient, and we report the youngest and the first UPD(2)mat with PREPL novel homozygous pathogenic mutation case, which expand the mutation spectrum of PREPL gene.


Subject(s)
Frameshift Mutation , Myasthenic Syndromes, Congenital/genetics , Prolyl Oligopeptidases/genetics , Uniparental Disomy , Chromosomes, Human, Pair 2/genetics , Female , Humans , Infant , Myasthenic Syndromes, Congenital/pathology
13.
Pharmacol Res ; 151: 104558, 2020 01.
Article in English | MEDLINE | ID: mdl-31759088

ABSTRACT

Prolyl oligopeptidase (PREP) is a serine protease that has been studied particularly in the context of neurodegenerative diseases for decades but its physiological function has remained unclear. We have previously found that PREP negatively regulates beclin1-mediated macroautophagy (autophagy), and that PREP inhibition by a small-molecule inhibitor induces clearance of protein aggregates in Parkinson's disease models. Since autophagy induction has been suggested as a potential therapy for several diseases, we wanted to further characterize how PREP regulates autophagy. We measured the levels of various kinases and proteins regulating beclin1-autophagy in HEK-293 and SH-SY5Y cell cultures after PREP inhibition, PREP deletion, and PREP overexpression and restoration, and verified the results in vivo by using PREP knock-out and wild-type mouse tissue where PREP was restored or overexpressed, respectively. We found that PREP regulates autophagy by interacting with protein phosphatase 2A (PP2A) and its endogenous inhibitor, protein phosphatase methylesterase 1 (PME1), and activator (protein phosphatase 2 phosphatase activator, PTPA), thus adjusting its activity and the levels of PP2A in the intracellular pool. PREP inhibition and deletion increased PP2A activity, leading to activation of death-associated protein kinase 1 (DAPK1), beclin1 phosphorylation and induced autophagy while PREP overexpression reduced this. Lowered activity of PP2A is connected to several neurodegenerative disorders and cancers, and PP2A activators would have enormous potential as drug therapy but development of such compounds has been a challenge. The concept of PREP inhibition has been proved safe, and therefore, our study supports the further development of PREP inhibitors as PP2A activators.


Subject(s)
Autophagy , Gene Deletion , Prolyl Oligopeptidases/antagonists & inhibitors , Prolyl Oligopeptidases/genetics , Protein Phosphatase 2/metabolism , Animals , Autophagy/drug effects , Cell Line , Enzyme Inhibitors/pharmacology , HEK293 Cells , Humans , Male , Mice, Inbred C57BL , Mice, Knockout , Parkinson Disease/drug therapy , Parkinson Disease/genetics , Parkinson Disease/metabolism , Prolyl Oligopeptidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...